The slower the escalation, the better the GI tolerability during the induction period
After starting treatment, the medication begins influencing the brains hunger signals and slowing stomach emptying, which allows you to feel fuller for a longer time after meals
Comorbidities that may matter in the assessment include type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea, PCOS, fatty liver disease, joint problems linked to excess weight, and cardiovascular disease
GLP-1s are considered safe and unprecedentedly effective aids to weight loss and associated health risks, such as type 2 diabetes
This makes it an excellent choice for those who want to gain muscle without the bloat or jitters associated with other performance enhancers
Most patients experience mild to moderate nausea that peaks in days 37 after injection and resolves within 24 weeks as the body adapts